Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL1306802 | 0.98 | TSHR (0.40) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL7681385 | 0.88 | MGAM (0.35) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL3282107 | 0.84 | TSHR (0.40) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL10011809 | 0.83 | TSHR (0.36) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL11065243 | 0.82 | TSHR (0.39) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL2420651 | 0.80 | USP2 (0.37) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL242271 | 0.80 | GAA (0.39) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL10011332 | 0.80 | TSHR (0.37) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL28587367 | 0.80 | ALDH1A1 (0.45) | HSD17B10GAALMNAALDH1A1KMT2A | |
| SCHEMBL28678362 | 0.79 | POLB (0.45) | TSHRHSD17B10LMNAUSP2RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9976049-B2 | Hydrophilic monolayer films | MITSUI CHEMICALS, INC. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20170044393-A1 | HYDROPHILIC MONOLAYER FILMS | MITSUI CHEMICALS, INC. (JP) | 2017-02-16 | — | — | US | disclosed |
| US-20150344711-A1 | INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATTER, AND HIGH-MOLECULAR-WEIGHT POLYMERIZATION INITIATOR | FUJIFILM CORPORATION (JP) | 2015-12-03 | — | — | US | disclosed |
| US-9130244-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2908376-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2015-08-19 | — | — | EP | disclosed |
| US-8470886-B2 | Topical ibuprofen formulations | NUVO RESEARCH INC. (CA) | 2013-06-25 | — | — | US | disclosed |
| US-20120232152-A1 | TOPICAL IBUPROFEN FORMULATIONS | NUVO RESEARCH INC. | 2012-09-13 | — | — | US | disclosed |
| EP-2479831-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | Ube Industries, Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| WO-2010101477-A1 | HYDRATE INHIBITORS | M-I SWACO NORGE AS (NO) | 2010-09-10 | — | — | WO | disclosed |
| US-5719138-A | CONTACTING WITH A DICITRATE CYCLIC DIESTER | UNIVERSITY OF FLORIDA (US) | 1998-02-17 | — | — | US | disclosed |
| US-5607964-A | ANTIDEPOSIT AGENTS USING DICITRATE CYCLIC DIESTERS | UNIVERSITY OF FLORIDA (US) | 1997-03-04 | — | — | US | disclosed |
| US-5604103-A | USING DICITRATE CYCLIC DIESTER | UNIVERSITY OF FLORIDA (US) | 1997-02-18 | — | — | US | disclosed |
| US-5601804-A | ANTIPLAQUE AGENT | THE UNIVERSITY OF FLORIDA (US) | 1997-02-11 | — | — | US | disclosed |
| US-5550259-A | DICITRATE CYCLIC DIESTER CAN BE USED TO PREVENT OR REDUCE THE EFFECTS OF CALCIFICATION-RELATED DISEASE | THE UNIVERSITY OF FLORIDA (US) | 1996-08-27 | — | — | US | disclosed |
| EP-0704057-A1 | NOVEL CLINICAL MARKER AND THERAPEUTIC AGENT IN KIDNEY STONE DISEASE AND METHODS OF USE | UNIVERSITY OF FLORIDA (US) | 1996-04-03 | — | — | EP | disclosed |
| WO-1995000844-A1 | NOVEL CLINICAL MARKER AND THERAPEUTIC AGENT IN KIDNEY STONE DISEASE AND METHODS OF USE | UNIVERSITY OF FLORIDA (US) | 1995-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232152-A1 | TOPICAL IBUPROFEN FORMULATIONS | ACSL1, ACSL6, ACSL4 | TSHR 4880/4885HSD17B10 198/4885MGAM 2352/4885 |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | SLC8A1, OR10J3, SLC8B1 | TSHR 3669/4885HSD17B10 1563/4885MGAM 4087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.